Table 5.
Interaction of vaginal micro-environment factors on CIN by GMDR analysis
| Group | Model | TBA | P | CVC |
|---|---|---|---|---|
| HPV16 negative | ||||
| CIN1 | A1 | 0.4763 | 0.9453 | 6/10 |
| A1/ A3 | 0.6058 | 0.0510 | 10/10 | |
| A1/A3/A4 | 0.5457 | 0.1719 | 7/10 | |
| A1/A2/A3/A4 | 0.5570 | 0.0547 | 10/10 | |
| CIN2/3 | A4 | 0.5926 | 0.1719 | 7/10 |
| A3/A4 | 0.6266 | 0.0547 | 8/10 | |
| A2/A3/A4 | 0.5950 | 0.0107 | 10/10 | |
| A1/A2/A3/A4* | 0.6394 | 0.0107 | 10/10 | |
| HPV16 positive | ||||
| CIN1 | B1 | 0.4499 | 0.9893 | 5/10 |
| B1/B4 | 0.5180 | 0.0547 | 7/10 | |
| B1/B4/B6* | 0.5832 | 0.0107 | 10/10 | |
| B2/B3/B5/B7 | 0.5110 | 0.3770 | 3/10 | |
| B2/B3/B4/B5/B7 | 0.5132 | 0.3770 | 7/10 | |
| B2/B3/B4/B5/B6/B7 | 0.5496 | 0.3770 | 5/10 | |
| B1/B2/B3/B4/B5/B6/B7 | 0.5521 | 0.3770 | 10/10 | |
| CIN2/3 | B6 | 0.6284 | 0.0107 | 10/10 |
| B4/B6 | 0.6266 | 0.0547 | 8/10 | |
| B3/B6/B7 | 0.5547 | 0.1719 | 4/10 | |
| B1/B3/B6/B7 | 0.5742 | 0.1719 | 4/10 | |
| B1/B3/B4/B6/B7 | 0.6333 | 0.0547 | 8/10 | |
| B1/B2/B3/B4/B6/B7* | 0.6394 | 0.0107 | 10/10 | |
| B1/B2/B3/B4/B5/B6/B7 | 0.6009 | 0.0107 | 10/10 |
A1-A4 represents vagina cleanness, H2O2, β-glucuronidase, neuraminidase. B1-B7 represents vagina cleanness, PH, H2O2, β-glucuronidase, coagulase, neuraminidase, and leukocyte esterase respectively. TBA represents testing balance accuracy. CVC represents cross validation consistency. *The best interaction model adjusted by FAC1, FAC2 and FAC3.